![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1269614
¼¼°èÀÇ Áúº´ ¿¹Ãø ºÐ¼® ½ÃÀå ±Ô¸ð Á¶»ç ¹× ¿¹Ãø : ÄÄÆ÷³ÍÆ®º°, Àü°³º°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° ºÐ¼®(2022-2029³â)Global Predictive Disease Analytics Market Size study & Forecast, by Component by Deployment, by End User and Regional Analysis, 2022-2029 |
¼¼°èÀÇ Áúº´ ¿¹Ãø ºÐ¼® ½ÃÀåÀº 2021³â¿¡ ¾à 16¾ï 3,000¸¸ ´Þ·¯·Î Æò°¡µÇ°í, ¿¹Ãø±â°£ 2022-2029³â¿¡´Â 22.70% ÀÌ»óÀÇ °ÇÀüÇÑ ¼ºÀå·ü·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
¿¹Ãø ºÐ¼®Àº µ¥ÀÌÅÍ ¸¶ÀÌ´×, Åë°è, ¸ðµ¨¸µ, ÀΰøÁö´É, ¸Ó½Å ·¯´× µî Ãֽе¥ÀÌÅ͸¦ ºÐ¼®Çϰí ÇâÈÄ ¿¹ÃøÀ» ¼öÇàÇÏ´Â ´Ù¾çÇÑ ±â¼úÀ» »ç¿ëÇÕ´Ï´Ù. ÇコÄÉ¾î ºÐ¾ß¿¡¼´Â ¿¹Ãø ºÐ¼®ÀÇ È°¿ëÀ¸·Î ¿©·¯ ¿µ¿ª¿¡¼ °³¼±ÀÌ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. ¿©±â¿¡´Â º´¿ø °ü¸®, °ø±Þ¸Á ´Ü¼øÈ, ¸¸¼º Áúȯ Ä¡·á µîÀÌ Æ÷ÇԵ˴ϴÙ. Áúº´ ¿¹Ãø ºÐ¼® ½ÃÀåÀº ¸ÂÃãÇü ÀÇ·áÀÇ »ó½Â°ú ÇコÄÉ¾î »ê¾÷¿¡¼ÀÇ µðÁöÅÐ ±â¼ú äÅÃÀÇ Áõ°¡¿Í °°Àº ¿äÀÎÀ¸·Î È®´ëµÇ°í ÀÖ½À´Ï´Ù.
¿¹Ãø ºÐ¼® µµ±¸´Â Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºêÀÇ Áõ°¡¿Í ÀÌ ºÐ¾ß¿¡ ´ëÇÑ ÀçÁ¤ ÅõÀÚÀÇ Áõ°¡°¡ Áߺ¹µÇ¾î ÇコÄÉ¾î ºÐ¾ß¿¡¼ ´õ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î 2023³â 2¿ù À¯·´À§¿øÈ¸´Â ½Å±Ô¾Ï Ä¡·áÁ¦ÀÇ ÀÓ»ó µ¥ÀÌÅ͸¦ ¼öÁý¡¤Æò°¡Çϱâ À§ÇÑ AI ±â¹Ý Ç÷§ÆûÀ» ±¸ÃàÇÏ°í ±ÔÁ¦ ´ç±¹°ú HTA ±â°üÀÇ Æò°¡¸¦ Áö¿øÇÏ´Â °ÍÀ» ¸ñÀûÀ¸·Î ÇÑ »õ·Î¿î ÇÁ·ÎÁ§Æ®¿¡ 720¸¸ ´Þ·¯¸¦ ÇÒ´çÇß½À´Ï´Ù. ÀÌ¿Í ¸¶Âù°¡Áö·Î ¹Ì±¹ Á¤ºÎ´Â ÀÓ»ó µ¥ÀÌÅÍ, Áö¿ª °Ç° ½ÇÀû, ÀÇÇÐÀû ¹× °úÇÐÀû Áö½Ä°ú °°Àº ÁÖÁ¦¿¡ ´ëÇÑ ¸¹Àº ¿¬¹æ Á¤ºÎ µ¥ÀÌÅͺ£À̽º¿¡¼ µ¥ÀÌÅ͸¦ °áÇÕÇÑ HealthData.gov Æ÷ÅÐ µîÀÌ ºÐ¾ß¿¡¼ ¸¹Àº ³ë·ÂÀ» ½ÃÀÛÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ±â¼úÀÇ ±Þ¼ÓÇÑ ¹ßÀü°ú ¾öû³ ÅõÀÚ·Î ÇコÄÉ¾î ºÐ¾ß°¡ ºü¸£°Ô µðÁöÅÐȵǰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼® µµ±¸´Â ȯÀÚÀÇ Ã¼·ù¸¦ °ü¸®Çϱâ À§ÇØ Àü¼¼°èÀûÀ¸·Î »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÇコÄÉ¾î ºÐ¼®À» »ç¿ëÇϸé Á÷¿øÀÇ »ý»ê¼ºÀ» ³ôÀ̰í ȯÀÚ °ü¸®¸¦ °ÈÇÏ¸ç °£º´ÀÎÀÇ ½ºÆ®·¹½º¸¦ ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. ¿¬±¸ ¹× Äɾ Çõ½ÅÀ» °¡Á®¿À±â À§ÇØ µ¥ÀÌÅÍ ºê¸¯½º´Â 2022³â 3¿ù ÀÇ·á ¹× »ý¸í°úÇÐ ¾÷°è¸¦ À§ÇÑ ÆÐ·¯´ÙÀÓ '·¹ÀÌÅ©ÇϿ콺'¸¦ °³¹ßÇß½À´Ï´Ù. Áúº´ ¿¹Ãø, ÀÇ·á ¿µ»ó ºÐ·ù, ¹ÙÀÌ¿À¸¶Ä¿ ½Äº°À» À§ÇÑ ºÐ¼®, µ¥ÀÌÅÍ °ü¸®, ÃÖ÷´Ü AI¸¦ ¸ðµÎ ÇϳªÀÇ Ç÷§Æû¿¡¼ ¼öÇàÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ¿Í °°ÀÌ ÀÇ·á ºÐ¾ß¿¡¼ÀÇ Á¦Ç° °³¹ß Ȱµ¿°ú Á¤ºÎ·ÎºÎÅÍÀÇ ÀÚ±Ý Á¦°øÀÇ Áõ°¡°¡ ½ÃÀåÀÇ ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª Áúº´ ¿¹Ãø ºÐ¼®ÀÇ ºñ¿ëÀÌ ³ô±â ¶§¹®¿¡ 2022³âºÎÅÍ 2029³â±îÁöÀÇ ¿¹Ãø±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» ÀúÇØÇϰí ÀÖ½À´Ï´Ù.
Áúº´ ¿¹Ãø ºÐ¼® ¼¼°è ½ÃÀå Á¶»ç¿¡¼ °í·ÁµÈ ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, Áß³²¹Ì ¹× ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«ÀÔ´Ï´Ù. ºÏ¹Ì´Â ÇコÄÉ¾î »ê¾÷¿¡¼ÀÇ µðÁöÅÐ ±â¼ú µµÀÔÀÇ Áõ°¡, ¸ÂÃãÇü ÀÇ·áÀÇ ¿¬±¸°³¹ßÀÇ Áõ°¡, »ê¾÷¿¡ ´ëÇÑ Á¤ºÎÀÇ Áö¿øÀÇ Áõ°¡¿¡ ÀÇÇØ ¼öÀ͸鿡¼ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù. ÇÑÆí ¾Æ½Ã¾ÆÅÂÆò¾çÀº Á¤ºÎ Áö¿ø ¹× ÀÌ´Ï¼ÅÆ¼ºê Áõ°¡, ¸¸¼º Áúȯ Áõ°¡, Á¦Ç° °³Ã´À» À§ÇÑ Á¦ÈÞ Áõ°¡, ÁÖ¿ä ÁøÀÔ ±â¾÷ÀÇ Áö¿ª È®´ë, Á¤ºÎ ±â°ü ¹× ºñ¿µ¸® ´Üü ½ÃÀå ÁøÀÔ µîÀÇ ¿äÀÎÀ¸·ÎºÎÅÍ ¿¹Ãø±â°£ µ¿¾È ÃÖ°íÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ÀÌ ¿¬±¸ÀÇ ¸ñÀûÀº ÃÖ±Ù ¸î ³â µ¿¾È ´Ù¾çÇÑ ºÎ¹®°ú ±¹°¡ÀÇ ½ÃÀå ±Ô¸ð¸¦ ÆÄ¾ÇÇÏ°í ¾ÕÀ¸·Î ¼ö³â°£ÀÇ ½ÃÀå ±Ô¸ð¸¦ ¿¹ÃøÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ º¸°í¼´Â Á¶»ç ´ë»ó ±¹°¡ »ê¾÷ÀÇ ÁúÀû ¹× ¾çÀû Ãø¸éÀ» Æ÷ÇÔÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.
¶ÇÇÑ ½ÃÀåÀÇ ¹Ì·¡ ¼ºÀåÀ» ±ÔÁ¤ÇÏ´Â ÃËÁø¿äÀΰú °úÁ¦ µî Áß¿äÇÑ Ãø¸é¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸µµ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ °æÀï »óȲ°ú ÁÖ¿ä ±â¾÷ÀÌ Á¦°øÇÏ´Â ÄÄÆ÷³ÍÆ®¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®°ú ÇÔ²² ÀÌÇØ°ü°èÀÚ°¡ ÅõÀÚÇÒ ¼ö ÀÖ´Â ¹Ì½ÃÀû ½ÃÀå¿¡¼ÀÇ ÀáÀçÀûÀÎ ±âȸµµ Æ÷ÇÔÇϰí ÀÖ½À´Ï´Ù.
Global Predictive Disease Analytics Market is valued approximately USD 1.63 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 22.70% over the forecast period 2022-2029. Predictive analytics uses a variety of techniques to analyze the most recent data and make future predictions, including data mining, statistics, modelling, artificial intelligence, and machine learning. The healthcare sector has made improvements in several areas by using predictive analytics. These include administering a hospital, simplifying the supply chain, and treating chronic diseases. The Predictive Disease Analytics market is expanding because of factors such as rising emergence of personalized medicine, rising adoption of digital technologies in healthcare industry.
Predictive analytical tools are being more widely used in the healthcare sector due to a combination of rising government initiatives and rising financial investments in the area. For instance, in February 2023, the European Commission allocated USD 7.2 million for a new project that aims to create an AI-based platform for gathering and evaluating clinical data on novel oncology drugs to help regulators' and HTA agencies' evaluations of those drugs. Similar to this, the American government has launched a number of initiatives in this area, such as the HealthData.gov portal, which compiles data from a number of federal databases on subjects like clinical data, community health performance, and medical and scientific knowledge. In addition, the healthcare sector is rapidly becoming digitalized due to the quick development of technology and significant investment made by the sector. These analytical tools are being used all around the world to control patients' retention. The use of healthcare analytics also boosts employee productivity, enhances patient care, and lessens the stress on carers. To bring innovation in research and care, Databricks developed the Lakehouse paradigm for the healthcare and life science industries in March 2022. Analytics, data management, and cutting-edge AI for disease prediction, medical picture classification, and biomarker identification can all be done on one platform. Thus rising product development activities and government funding in healthcare sector is catering the market growth. However, the high cost of Predictive Disease Analytics stifles market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Predictive Disease Analytics Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to rising adoption of digital technologies in healthcare industry, rising research and development of personalized medicine and rising government support to the industry. Whereas Asia Pacific is expected to grow with a highest CAGR during the forecast period, owing to factors such as increasing government support and initiative, growing chronic disease in the region an increase in the number of collaborations for product development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and component offerings of key players. The detailed segments and sub-segment of the market are explained below.